Table 5.
ELISA and MBA results for each antigen in neurocysticercosis patients with only calcified (non-viable) cysts (n = 46)
| Calcified Cysts (n = 46) | |||||||
|---|---|---|---|---|---|---|---|
| Test | Area | 95% CI | SE | P | Cut-off | S (%) | SP (%) |
| T24H-his ELISA | 0.88 | 0.841–0.928 | 0.022 | < 0.001 | 23.3 | 34.8 | 96.5 |
| GST-Ts8B2 ELISA | 0.86 | 0.811–0.911 | 0.026 | < 0.001 | 34.5 | 15.2 | 96.5 |
| GST-T24H ELISA | 0.91 | 0.869–-0.950 | 0.021 | < 0.001 | 21.1 | 43.5 | 96.5 |
| T24H-his MBA | 0.82 | 0.754–0.881 | 0.032 | < 0.001 | 9.2 | 32.6 | 96.5 |
| GST-Ts8B2 MBA | 0.55 | 0.445–0.647 | 0.052 | 0.341 | 250.0 | 13.0 | 91.2 |
| GST-T24H MBA | 0.84 | 0.774–0.909 | 0.034 | < 0.001 | 4.0 | 37.0 | 96.5 |
Abbreviations: Area area under the ROC curve, CI confidence interval, SE standard error, Cut-off serological index value selected as the cut-off for each test, S (%) sensitivity percentage, Sp (%) specificity percentage